Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, held an Investor Symposium for investors yesterday. The presentations are now available to view on the Company website:
http://www.polarean-ir.com/
Enquiries:
| Polarean Imaging plc | ||||
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR | |||
| Richard Morgan, Chairman |
| |||
| Walbrook PR | Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com | |||
| Anna Dunphy / Paul McManus | Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893 | |||
